Peptide Therapy FAQs As a general category of treatment, peptide therapy is not specifically FDA-approved
However, when you use B12 injections, the treatment goes directly into your bloodstream
Thus, based on the understanding of the role of the HGF/c-Met signaling pathway and the uniqueness of c-Met in HCC, more and more therapeutic strategies target c-Met and the interaction between c-Met and downstream signaling mediators instead of the interaction between HGF and c-Met because of the varying activation of c-Met
Managing common side effects Like other weight loss medications, tirzepatide can also cause mild to moderate gastrointestinal side effects such as nausea (most common), diarrhea, and constipation, especially during the start of treatment or when the dose is increased
Patients with gout require ongoing management of cardiovascular risk and monitoring for associated co-morbidities, e.g